You are here

Home

Biblio

[ Author(Desc)] Title Type Year
Filters: Keyword is Amyloid beta-Peptides  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Andrews SJ, Fulton-Howard B, O'Reilly P, Marcora E, Goate AM.  2021.  Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome.. Ann Neurol. 89(1):54-65.
B
Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD.  2020.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.. JAMA Neurol. 77(7):849-862.
Brickman AM, Manly JJ, Honig LS, Sanchez D, Reyes-Dumeyer D, Lantigua RA, Lao PJ, Stern Y, Vonsattel JPaul, Teich AF et al..  2021.  Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.. Alzheimers Dement. 17(8):1353-1364.
D
Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL et al..  2018.  Sex-specific genetic predictors of Alzheimer's disease biomarkers.. Acta Neuropathol. 136(6):857-872.
E
Ewers M, Biechele G, Suárez-Calvet M, Sacher C, Blume T, Morenas-Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G et al..  2020.  Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation.. EMBO Mol Med. 12(9):e12308.
F
Friedberg JS, Aytan N, Cherry JD, Xia W, Standring OJ, Alvarez VE, Nicks R, Svirsky S, Meng G, Jun G et al..  2020.  Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype.. Sci Rep. 10(1):2924.
I
Ibañez L, Bahena JA, Yang C, Dube U, Farias FHG, Budde JP, Bergmann K, Brenner-Webster C, Morris JC, Perrin RJ et al..  2020.  Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease.. Acta Neuropathol Commun. 8(1):196.
K
Kim JPyo, Kim B-H, Bice PJ, Seo SWon, Bennett DA, Saykin AJ, Nho K.  2021.  BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer's disease.. Alzheimers Res Ther. 13(1):164.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A et al..  2019.  Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet. 51(3):414-430.
L
Lananna BV, McKee CA, King MW, Del-Aguila JL, Dimitry JM, Farias FHG, Nadarajah CJ, Xiong DD, Guo C, Cammack AJ et al..  2020.  /YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer's disease pathogenesis.. Sci Transl Med. 12(574)
N
Nho K, Nudelman K, Allen M, Hodges A, Kim S, Risacher SL, Apostolova LG, Lin K, Lunnon K, Wang X et al..  2020.  Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology.. Alzheimers Dement. 16(9):1213-1223.
P
Patrick E, Olah M, Taga M, Klein H-U, Xu J, White CC, Felsky D, Agrawal S, Gaiteri C, Chibnik LB et al..  2021.  A cortical immune network map identifies distinct microglial transcriptional programs associated with β-amyloid and Tau pathologies.. Transl Psychiatry. 11(1):50.
W
Wang S, Lindroth H, Chan C, Greene R, Serrano-Andrews P, Khan S, Rios G, Jabbari S, Lim J, Saykin AJ et al..  2021.  A Systematic Review of Delirium Biomarkers and Their Alignment with the NIA-AA Research Framework.. J Am Geriatr Soc. 69(1):255-263.
Y
Yan Q, Nho K, Del-Aguila JL, Wang X, Risacher SL, Fan K-H, Snitz BE, Aizenstein HJ, Mathis CA, Lopez OL et al..  2021.  Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging.. Mol Psychiatry. 26(1):309-321.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer